SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000929638-24-001015
Filing Date
2024-03-13
Accepted
2024-03-13 18:04:39
Documents
1
Group Members
NSV PARTNERS III GP, LLCNSV PARTNERS III, LPSOMASUNDARAM SUBRAMANIAM

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 10 schedule13da.htm SC 13D/A 77366
  Complete submission text file 0000929638-24-001015.txt   79068
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Subject) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92974 | Film No.: 24747269
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830
Business Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830 2126885100
NSV Investments I, L.P. (Filed by) CIK: 0001889184 (see all company filings)

IRS No.: 352613353 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A